Stay updated on Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.

Latest updates to the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page
- Check5 days agoChange DetectedRevision notes updated: added Revision: v3.4.3 and removed Revision: v3.4.2. These are backend/versioning updates and do not change the study details or user-facing content on the page.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedThe page shows Revision: v3.4.2 and removes the funding/operating status notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide funding notice was added. The page revision shows version v3.4.1 replacing v3.4.0.SummaryDifference0.4%

- Check48 days agoChange DetectedGlossary has been added to the page to help users understand terms used in the study record. The page now shows new labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the older variants 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, representing a platform version update with no substantive changes to the study page. No study data, eligibility criteria, or results were modified.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded a consolidated 'Locations' section listing sites in CA, GA, IL, OR, PA, and TN and removed the separate 'California Locations', 'Georgia Locations', 'Illinois Locations', 'Oregon Locations', 'Pennsylvania Locations', and 'Tennessee Locations' headers. Revision updated to v3.3.3.SummaryDifference0.6%

Stay in the know with updates to Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.